VALAPHARMA
ActiveSummary
VALAPHARMA has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.0m and a net result of €591,858. Equity is growing by about 9.4% per year across the filed financial years. Its solvency ranks better than 81% of 11,207 sector peers (NACE 68, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
07-07
Gazette deed
Reappointment: Valérie LEVIE (director)Permanent representative: Valérie LEVIE · Legal-form conversion · Capital conversion10 facts ▸
- Legal-form conversion, “société à responsabilité limitée” (deed in French)
- Capital conversion, “mise à disposition pour distributions futures” (deed in French)
- Amendment of the articles
- Capital
- Director reappointment, Valérie LEVIE (director (not named in the articles))
- Other provision, “décharge gérant démissionnaire, reportée prochaine assemblée générale annuelle” (deed in French)
- Permanent representative, Valérie LEVIE
- Registered office clause, “5020 Vedrin (Namur),rue de l’Eau Vive,56” (deed in French)
- Power of attorney
- General meeting, “Toutes ces résolutions ont été adoptées à l'unanimité” (deed in French)
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.